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Introduction
The realm of biomaterials, under which biomedical ma-
terials can be categorised, has a broad definition base 
and recognises materials that are synthesized or naturally 
sourced. Biomaterials are normally those that come into 
contact with live tissue and physiological fluids. They 
have applications as prostheses to replace lost function 
of joints or to replace bone tissue, for diagnosing medical 
conditions, as a form of therapy, or as a storage unit.1 The 
diversity and scope of biomaterials science research, and 
especially its application to the improvement of trauma, 
disease, and congenital defects in the human condition, 
are making this branch of science increasingly dominant 
and topical in many countries. An exciting aspect is that 
such research is interdisciplinary. The varied problems of 
the human condition that biomaterials research addresses 
occupy the efforts not only of medical doctors who act as 
the end users of such technology, but also those of chem-
ists, physicists, engineers, and biologists in creating the 
technological advances. Chemistry, in particular, plays a 
major role in such research, after all it is the foundation 
stone on which biomaterials polymer science and bio-
medical scaffold materials are built.
The replacement of any bone due to disease or trauma 
needs an implant. This implant can fall under one of three 
categories: autograft (fresh, living bone tissue harvested 
from somewhere else on the patient’s body such as the 
hip), allograft (living bone tissue donated by other indi-
viduals that is sourced from a bone bank, or xenograft (a 
synthetic bone substitute that lacks any living component 
but which could potentially act as a scaffold to support 
cells, etc. While autografts represent the gold standard of 
bone implants in terms of minimisation of rejection is-
sues, the pain of bone harvesting and the limitations of 
how much to harvest are disadvantageous. Allografts, 
alternative bone replacement materials, can have body 
rejection issues that couple with risks of disease transmis-
sion and paucity of material available for implants. The 
rationale, therefore, for development of xenograft materi-
als is to reduce reliance on autograft and allograft bone. 
Within the area of biomedical materials, the quest for suit-
able materials that act as osteoconductive xenograft scaf-
folds viz. ones capable of supporting new bone deposition 
and its proliferation, has been an avid subject globally. 
The keenness of interest in xenograft implantation materi-
als in general has been further accentuated by the recently 
emerging area of Tissue Engineering which, according to 
Langer and Vacanti2 (the pioneering scientists in the field) 
applies the principles of biology and engineering to the 
development of functional substitutes for damaged tissue. 
In contrast to conventional xenograft scaffold research, 
the scaffold referred to in Tissue Engineering is effective-
ly a biodegradable (usually polymeric) three dimensional 
device. It serves as a cell transplant vehicle for bringing 
about formation of the structural and functional tissue 
units by the cells that have been transplanted.
Bone and its Chemical and Morphological 
Characteristics
Bone is a living interdigitated (or interlayered) compos-
ite of collagen protein and calcium phosphate platelets, 
the main mineral phase of which is carbonated calcium 
hydroxyapatite. Calcium hydroxyapatite, stoichiometri-
cally Ca
10
(PO
4
)
6
(OH)
2
, is the hydroxy end group member 
of the complex apatite family and it has a more complex 
chemistry than the related fluorapatite and chlorapatite 
compounds. When prepared by precipitation from aque-
ous solution, the Ca:P ratio varies from 1.50-1.66 rather 
than being reproducibly 1.67, the value expected from its 
stoichiometry.3 Structures categorised as being part of the 
apatite family have had their generic descriptor coined 
from the Greek word apato - deceit.4 They have the char-
acteristic and interesting property of substitutional lability 
in that the cationic and anionic components of the lattice 
structure, e.g. the -PO
4
, -OH and Ca
2+
, can be partially 
replaced with others when in solutions containing ex-
changeable ions. When lattice substitutions occur in cal-
cium hydroxyapatite, the physical properties of the solids, 
i.e. their solubility and crystal morphology, can change 
markedly from the state prior to the lattice substitutions. 
Biomineralization processes lead to bone deposition in 
the body and they occur in a complex physiological fluid. 
The composition of the mineralized apatitic portion of 
bone is not stoichiometrically pure but rather it exists as 
a carbonated calcium hydroxyapatite doped with various 
other inorganic elements and/or organic ions. It was pro-
posed in 1958 by Neuman et al.5 that the mean composi-
tion of bone was [Ca
9
(H
3
O)
2
(PO
4
)
6
][Ca, Mg
0.3
,Na
0.3
,CO
3
,
citrate
0.3
]. A more recent report6 has stated that its chemi-
cal composition can be approximately given by Ca
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4
)
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 where □ 
can equate to a lattice vacancy. In reality, it is difficult to 
give an exact composition of bone as it varies with species, 
the age of the vertebrate, and the location of bone in the 
body. Bone also has a specific architecture consisting of 
cortical bone, the harder outer layer of bone, and cancel-
lous bone, which is described as being the softer, spongier 
porous portion residing inside the bone. The cancellous 
architecture is created by deposition and resorption pro-
cesses that occur during bone formation as a result of the 
actions of bone tissue-associated cells such as osteoblasts, 
osteoclasts and osteoblasts.7 The overall porous architec-
ture of bone that acts as a hard tissue support for the cel-
lular or parenchymal (living) component of bone is char-
acterised by its interconnected porous channels, known as 
the trabecular network, that allow the transport of blood 
A
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through this living tissue.8
Any hard tissue replacement material for bone must thus 
attempt to replicate the typical bone architecture and be 
composed preferably of calcium phosphate materials that 
are not only biocompatible with the body but also able to 
be remodelled interfacially. This then allows a) new bone-
apatite to be co-deposited with collagen after a process 
of dissolution-re-precipitation of the bone-implant inter-
face and, b) new bone tissue to penetrate the implant at 
the bone-implant interface to provide a securely bonded 
bone-implant interface that effectively lodges the bone 
in its position. The so-termed bioactivity of the bone re-
placement material is important as such materials allow a 
direct chemical bond (without any so-called intervening 
fibrous tissue) to occur between natural bone tissue and 
the implant. Calcium hydroxyapatites have this property. 
This contrasts directly with the so-called bioinert (or bio-
tolerant) materials represented by e.g. hard ceramics such 
as alumina, zirconia, stainless steel, and titanium. These 
bond to bone tissue purely through an intervening fibrous 
tissue layer of varying thickness which separates natural 
bone tissue from the implant.8 Given these needed attri-
butes for bone tissue replacement, cancellous bovine bone 
arguably is the ideal, almost ready-to-use material. After 
processing (see below), this bone already possesses the 
desired mineral composition and the necessary architec-
ture to allow bone modelling at its interface as well as 
tissue in-growth.
Our main focus on producing xenograft bone replace-
ment materials has been to use the plentiful and relatively 
low cost animal bone from our large cattle herds. This 
can be done in NZ because of the strict auditing/tracking 
and MAF/biosecurity procedures that show the country, 
historically, not to have had any serious, notifiable diseas-
es afflicting its herds and especially Bovine Spongiform 
Encephalopathy (BSE). It has been allegedly that con-
sumption of meat affected with this disease led to human 
contraction of the fatal brain-wasting disease known as 
variant-Creuztfeldt-Jacob disease (v-CJD) in the UK. The 
continued BSE-free status of NZ (and Australia) allows 
bone material for biomedical applications to be sourced 
from the country’s mainstream cattle herds rather than 
from expensive controlled herds, viz. specially selected 
and certifiably BSE-free, that have to be used overseas for 
bone-sourced biomedical materials such as Bio-Oss®.9,10 
From the NZ perspective, this has the potential to produce 
a cheaper, high value biomedical commodity out of a tra-
ditionally low value material currently used for fertiliser 
or disposed of into the environment.
Processing Bovine Bone into Xenograft 
Cubes or Powders
The work performed at MIRINZ (NZ Meat Industry Re-
search Institute) and Waikato’s Chemistry Department in 
generating xenograft materials and powders from bovine 
bone has been described previously and the serious reader 
is directed to the literature.10,11
Xenografts
For the preparation of xenografts, it is necessary to cut 
cubes of cancellous bone from the condyle portion of the 
bovine femur bone using a sharp band saw. The condyle 
is the rounded part of a bone (here, the femoral bone of 
a bovine that supports its bulk) that fits into the socket of 
another bone to form a joint. The reason bovine condyles 
are suited to forming xenograft cubes lies in the relatively 
large size of the condyles. There is enough cancellous 
bone in a typical (mature) bovine condyle to produce three 
to four cubes of materials ca. 25 mm3 each, by cutting.10 
Other species of animals common to NZ agriculture such 
as sheep, deer, or even ostriches have femoral condyles 
which are either too small (sheep and deer) to allow the 
cutting or are overly spongy with a high fat content (os-
trich). Bone from other parts of the bovine skeleton, such 
as the rib can be processed, but it is more useful for form-
ing re-precipitated hydroxyapatite powders by acid dis-
solution processes rather than as xenografts.
In cutting the cubes, only frozen femoral condyles from 
supermarket abattoirs are used so as to have minimal seal-
ing of the bone pores by frictional heat-induced collagen-
to-gelatin transformation during cutting. The bone cubes 
are then boiled in water (conventional pressure cooker 
for 6 h and ca. 15 psi) to remove the bulk of the blood 
and fat present in the cubes. Initial work10,11 at Waikato 
involved pressure cooking of the bones followed by a 16 
h soak in NaOH, water rinse, and microwave heating of 
the bones (in water) to bp (to assist in fat removal). The 
bone cubes were then refluxed in AcOMe, which has a 
high affinity for fat, and then vigorous shaken or blown 
with compressed air to remove excess liquid prior to final 
drying. Cubes that contain fat are yellowed in appearance 
(Fig. 1). Deproteination of the defatted cubes was the 
next processing step and this was achieved by immers-
ing the defatted cubes in simple oxidising agents (NaOCl 
or H
2
O
2
). This removes the bulk of the collagen protein 
which, when interdigitated with carbonated hydroxyapa-
tite, gives the bovine bone a considerable degree of hard-
ness. Bone containing fat is yellow, defatted bone less so, 
but that with the protein removed has a whitened chalky 
consistency (Fig. 1). The last corresponds to carbonat-
ed hydroxyapatite with a significant loss in mechanical 
strength.12 This attribute means that it can be shaped for 
the desired implant by using a knife, scissors or a trephine 
(Fig. 1 shows a shaped implant).
Fig. 1. Bovine cancellous bone specimens. R to L: bovine can-
cellous bone cube prior to reflux with MeOAc showing the yel-
low colouration due to fat, defatted and deproteinated bovine 
cancellous bone as a bleached and chalky cube, and a shaped 
piece of defatted and deproteinated bone.
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In later research carried out by Mucalo and Foster13 and 
continued currently by Laird, Mucalo and Dias,14 the 
pressure cooked bone was not subjected to the time con-
suming solvent-assisted defatting and bleach-assisted de-
proteination procedures. Instead it was placed in alumina 
crucibles and sintered at 1000 ºC in a muffler furnace for 
several hours to burn off organic matter and leave the brit-
tle white mineral shell of the bone intact with its porous 
architecture (Fig. 2). Under these conditions, the bone 
mineral transforms from partially crystalline carbonated 
hydroxyapatite into crystalline hydroxyapatite.
Fig.2. Bovine cancellous bone after sintering at 1000ºC for 3 h.
Powders
A variety of methods have been used at Waikato to produce 
powders from bone.11 In previous studies milled animal 
bone powder was produced directly by crushing raw bone 
from a variety of available animal types, e.g. rib bones, 
sheep, bovine, corvine bone, etc., in a hydraulic press at 
100 psi and then pressure cooking for 4 h to remove tissue 
and fat. After drying the bone chips were ground further in 
a hammer mill to particle sizes <2 mm diam. Further pro-
cessing, such as AcOMe reflux (to remove further traces 
of fat), NaOH treatment, or more commonly acid-dissolu-
tion/re-precipitation (using NaOH) was then possible.
Although the acid-dissolution/re-precipitation methods 
produced powders, the residual fat and protein by-prod-
ucts arising from using raw bone as a starting material 
produced many problems, even when an intervening pres-
sure cooking step was used. For example, performing the 
acid digestions in HNO
3
 led to orange colouration of the 
resultant hydroxyapatite powders due to so-called xantho-
proteic reactions,13 which arise from interactions of the 
protein residues in collagen with the HNO
3
. Even HCl di-
gestions (in which xanthoproteic reactions are absent) of 
the milled bone powders led to opaqueness, most likely 
due to suspended collagen or fat. To remedy this, research 
by Mucalo and Foster13 involving cleaner acid digestion/
re-precipitation of already sintered bone pieces was per-
formed. This minimized problematic bone matrix-associ-
ated organic impurities by the burn off of these. Cleaner, 
white powders were obtained, especially from the HNO
3 
dilutions, leaving only the washing out of NO
3
- from the 
powders after re-precipitation in the subsequent cleanup 
process. Subsequently, the process developed14 was em-
ployed to provide kg-scale re-precipitated hydroxyapatite 
powders for plasma spraying. Here, the powders were 
passed through an Ar plasma under conditions where 
the re-precipitated hydroxyapatite particles become par-
tially molten and can be impacted onto stainless steel or 
titanium metal surfaces to form a plasma spray coating 
(another biomedical type application).15 Such coatings 
render metallic surfaces such as titanium or stainless steel 
more bioactive and give them the ability to bond more 
strongly to natural bone tissue through the mechanochem-
ically bonded hydroxyapatite layer; an example of such 
a coating is shown in Fig. 3. The heterogeneous and po-
rous nature of the plasma-sprayed hydroxyapatite coating 
not only improves the bioactivity of traditionally bioinert 
stainless steel or titanium substrates but may also provide 
a means of tissue in-growth so improving the bone-coat-
ing bonded interface.
Fig. 3. An SEM micrograph of plasma sprayed calcium hy-
droxyapatite coating on a titanium plate. The feedstock powder 
for this coating was produced by David Foster by re-precipita-
tion from an acid digest of sintered NZ bovine bone.
Spectroscopic and Microscopic 
Characterisation of the Xenografts and 
Powders Derived from Animal Bone
A wide range of spectroscopic, microscopic and other 
physical or mechanical testing techniques can be used to 
follow the chemical and physical changes that occur in 
the bone materials as they are processed for biomedical 
purposes. Thus, X-ray diffraction, solid state NMR and 
IR spectroscopy, atomic absorption spectroscopy (AAS), 
inductively coupled plasma optical emission spectrome-
try (ICP-OES), X-ray photoelectron spectrometry (XPS), 
scanning electron microscopy/energy dispersive X-ray 
analysis (SEM/EDXA), differential scanning calorim-
etry (DSC) and mechanical testing techniques (aimed at 
measuring the bulk modulus and yield stress values of the 
bone) have been used in our studies to characterise the 
bone matrices as a function of processing.10-12
Generally, IR, solid state magic angle spinning (MAS) 
13C NMR, and (to a lesser extent) XPS showed that the 
main changes during boiling/defatting/deproteination that 
led to the xenograft bone were due to the removal of fat 
and protein. As mentioned above, the remaining mineral 
residue retaining the original porous architecture of the 
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bone was hydroxycarbonate apatite.10 This was confirmed 
by an IR spectrum of the crushed bone (Fig. 4) with peaks 
characteristic of carbonate at 1451 and 872 cm-1 in ad-
dition to the apatitic phosphate-associated vibrational 
modes at 1036, 605 and 564 cm-1, respectively. However, 
when the defatting and bleach-assisted deproteination 
are replaced by sintering the boiled bone at 1000ºC, the 
bone mineral remaining is no longer the partially crys-
talline carbonated hydroxyapatite apatite; transformation 
to crystalline calcium hydroxyapatite occurs (Fig. 5), as 
evidenced by weak peaks at ca. 1450 cm-1 that indicate 
the carbonate stems from surface interactions between at-
mospheric CO
2
 and CaO present within the sintered bone. 
SEM micrographs of boiled/defatted/bleach-deprotein-
ated bone specimens showed the successful retention of 
the macroscopic structural detail of porous, cancellous 
bone along with the needed interconnected porosity chan-
nels for successful integration of the implant in vivo. For 
acid-digested/re-precipitated powders derived from bone, 
IR spectra show features typical of poorly crystalline cal-
cium hydroxyapatite; remaining features are usually due 
to carbonates substituted into the calcium hydroxyapatite 
lattice structure. These latter carbonates can arise by CO
2
 
contamination during the alkali-induced re-precipitation.
Fig. 4. FTIR spectrum (KBr disk) of ground bovine cancellous 
bone after subjection to boiling/defatting and deproteination.
Fig. 5. FTIR spectrum (KBr disk) of ground bovine cancellous 
bone after sintering at 1000ºC for 3 h.of the calcium hydroxy-
apatite from the acid digests.
Material strength tests predictably showed that prolonged 
boiling (6 h) followed by the deproteination hypochlorite 
treatment to give the chalky bone had a deleterious effect 
on the overall mechanical strength of the bovine bones 
tested.12 This is desired because the xenograft material 
that results is easily shaped. It is important, however, not 
to over-process otherwise attempts at shaping can result 
in complete collapse of the xenograft due to extreme brit-
tleness.
In vivo Study of the Implanted Boiled/
Defatted/Deproteinated Bovine Bone in a 
Sheep Model
The success and safety of an implant acting as a bone 
substitute can only be demonstrated properly through a 
series of in vitro and subsequently in vivo testing proce-
dures. In vitro testing involves subjecting the xenograft to 
a series of tests that evaluate its biocompatibility/irritation 
prior to placement in a living organism. One such widely 
used test is the hen’s egg test-chorioallantoic membrane 
(HET-CAM) test. This is described as a biocompatibil-
ity test intermediate to classical in vitro and in vivo test 
protocols.16 The test assesses the irritation potential of a 
particular substance by applying it directly to the highly 
vascularized chorioallantoic membrane of a developing 
chicken embryo that is <10 days old. Under these con-
ditions there is no visibly noticeable embryo, rather a 
beating heart in the middle of a network of vasculature 
(Fig. 6) which would develop over time into a full sized 
chick embryo given the correct incubation conditions. A 
scoring system16 evaluates the potential for tissue irrita-
tion, e.g. haemorrhaging by contact of the material with 
the blood vessels. Other tests that evaluate the material’s 
biocompatibility for physiological environments involve 
the responses of cells (from specially grown cell lines) to 
contact with the implant materials.17
Fig. 6. Hen egg chorioallantoic membrane (<10 days old) used 
to test materials for biocompatibility with living tissues. The 
dark image at right is the embryo chick heart. Typical test proto-
cols note the response of the vasculature to the materials. Photo 
courtesy of Dr Kavitha Babu, AgResearch, Ruakura.
The boiling/defatting/deproteination process of bovine 
bone was presumed sufficient to render it immunological-
ly inert for in vitro testing. One must note that fat removal 
is important because its presence in an implant can make 
it antigenic, viz.cause infection once surgically inserted.18 
However, the existing wide body of clinical knowledge 
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relating to in vivo bovine-derived materials in living or-
ganisms argued for a surgical protocol for in vivo implan-
tation of the bovine bone xenografts. This was developed 
by Warrick Bruce and Geoffery Horne (Massey Univer-
sity and Wellington School of Medicine, respectively) 
and approved by the Massey Animal Ethics Council. Sur-
geries were carried out at Massey’s Veterinary Teaching 
Hospital and the Wellington School of Medicine, and the 
Waikato bone cubes were implanted in an ovine femo-
ral defect model to evaluate their efficacy as an osteo-
conductive bone graft; the details of this work have been 
described in the biomedical literature.19 The surgical pro-
tocol involved the excising of an autograft bone sample 
from the sheep’s femur so at to create a defect for the pro-
cessed bovine xenoimplant. The excised autograft bone 
tissue was placed as a control in a defect created in the 
opposite femur of the same test animal. Twelve mature 
ewes with weights 55-70 kg were used in the study so as 
to avoid the normal growth processes of younger animals 
and minimize impact upon xenoimplant incorporation. 
The trephine implement removed 8 mm O.D. cylindrical 
cores of the xenoimplant from the (boiled/defatted/depro-
teinated) Waikato bone and this was sterilised (γ-radia-
tion) prior to implantation. The deposition of new bone 
tissue around the implants was monitored at 15-17, 30-32, 
and 56 days after surgery using fluorochrome label dyes 
that had been intravenously introduced at certain time pe-
riods after the surgical implantation. The sheep were hu-
manely euthanized ten weeks after surgery and the distal 
femurs harvested. De-muscled bone sections X-rayed and 
then non-decalcified thin sections embedded in resin for 
fluorescence microscopy study. Overall, the study sup-
ported bovine bone as osteoconductive in the ovine model 
used and the fluorescent labelling showed that new bone 
material grew over the implant. Furthermore, the xeno-
implant performed similarly or better to the autograft in 
osteoconductivity. This unexpected observation has been 
ascribed tentatively to the open, porous nature of the bo-
vine xenoimplant after trephining. This contrasts to the 
polished and sealed surface of the autograft which would 
have delayed tissue in-growth. In particular, the study has 
confirmed that boiled/defatted/deproteinated bovine bone 
is workable, easily shaped, and compatible to surgical 
procedure.
Further surgical work at Massey20 implanted boiled/de-
fatted/deproteinated bovine bone in a defective paw of 
a family’s pet dog. The void in the dog’s paw bone was 
cleaned out and replaced with a grafting mixture of au-
togenous cancellous bone and the Waikato xenoimplant. 
This procedure has as its ultimate aim not simply reduc-
ing dependence on the quantity of harvested autogenous 
bone needed but to use the osteoinductive properties of 
the autogenous bone for stimulation and propagation of 
bone growth and lead to bone growth in the osteoconduc-
tive xenoimplant portion of the graft.
The dog’s paw was X-rayed post-operatively at 1, 2, 6, 
and 10 months and showed over this time overall densi-
fication of bone in the region of the void. The dog itself 
was sound throughout this period and is still believed to 
be alive today at time of writing. Thus the bone developed 
at Waikato has immediate use as a xenograft material for 
veterinary purposes.
Current and Future Activities
Work at Massey University on implantations of the Waika-
to bovine bone in dogs continues while collaboration with 
Otago is on the development of a sintered bovine bone 
material with the strength lost by collagen removal par-
tially restored. Biocompatibility testing of these materials 
using the HET-CAM, as well as separate trials employing 
a specific cell line, viz. L929 (to assess whether cells pro-
liferate on these materials) would have been conducted by 
the time this article has gone to press. Eventually, an in-
vivo implantation trial in a suitable animal model (likely 
sheep) will also be considered on the basis of the initial 
biocompatibility testing results.
Conclusions
It has been shown that NZ-sourced bovine bone provides 
a useful bone replacement material for veterinary applica-
tions and holds strong promise in the future for human 
applications. Thus value has been added to what was for-
merly a low value resource in agriculture. Hopefully it 
will create a new, specialist niche export market for this 
country. 
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Learning Science
Education research in the 1970s, like other related areas, 
was dominated by quantitative work1 during an era for 
which social sciences sought to draw upon the successful 
scientific approach typically used in the physical sciences 
(in particular) to investigate teaching and learning.1,2 So if 
we felt a cohort of students did not understand some con-
cept, we tried to find out whether or not a different teach-
ing approach could fix their misconceptions.3 But how to 
do this? Well, drawing on a scientific approach, we would 
divide the class or classes up, teach one cohort the same 
way we always had, and the other cohort in our new way, 
and evaluate any differences in conceptual understanding 
using, e.g. a standardized topic test. Differences would be 
examined for statistical significance of evidence that our 
new approach to teaching had worked. And this is the way 
much research was done at the time. Control of variables, 
randomized sampling, and so on, were all embedded in 
such an approach to educational research.
At about this time, however, key research – some of it 
NZ-based – suggested teaching and learning was rather 
more complex. Investigation into how students arrive at 
their own views of scientific concepts, focused on student 
misconceptions, or alternative conceptions, viz. students’ 
views that are at variance with the accepted scientific 
viewpoint. Perhaps it is not that surprising that students 
harbour misconceptions for abstract concepts such as the 
kinetic theory, electricity, and force. But some student 
views of more common concepts are less easily under-
stood and it is likely that they are influenced by other 
factors such as cultural background. There are some un-
usual examples reported in the literature. For example, 
one study of misconceptions of Papua-New Guinean stu-
dents found some to believe that pregnancy occurs when 
a spirit child enters a woman rather than as a result of 
sexual intercourse.4 A Caribbean-based study found that 
some students believed that hair would grow more rapidly 
if it was cut during the full moon.5 Other researchers have 
suggested that some student misconceptions may arise as 
a result of the learning process itself.6 These studies might 
seem curious or odd but, overall, such studies suggested 
that factors other than the school environment and the 
teaching processes used were also influential in student 
learning. There are now huge bibliographies of student al-
ternative conceptions complied, some with several thou-
sand studies detailed.7
What is perhaps of more concern is the remarkable te-
nacity of many student misconceptions. Students in many 
cases seem unwilling to give up their prior beliefs even 
after instruction.8-10 Similarly, early research by Osborne 
and colleagues10 suggested that even very able students, 
i.e. those who passed exams with high marks, did not ac-
tually understand fundamental scientific concepts in ways 
we would desire.
What might be the overall origins of such problems, and 
what might we do about it? Let me consider this by look-
ing at what I think is a key factor; high, perhaps unrealis-
tic, expectations of our students.
Learning Chemistry in Higher Education
As mentioned above, considerable concern has been ex-
pressed in the literature about the high incidence, and re-
markable tenacity, of common student misconceptions. 
The vast bulk of this research is concerned with school 
students, but similar issues are reported also for students 
of advanced chemistry from the higher education sector. 
Some higher education research reports give a real sense 
of frustration experienced by teachers or lecturers as they 
struggle to deal with student misconceptions.11-16 While 
there are a number of concepts that students traditionally 
find difficult such as aspects of physical chemistry, like 
thermodynamics and electrochemistry,11 researchers seem 
more concerned at the prevalence of student misconcep-
tions for even very simple concepts12,15,16 For example Her-
ron16 comments that for his first-year chemistry students 
fewer than 50% of the students seemed to comprehend 
that it was Cl- that was in table salt and not Cl
2
 or that 
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